Friday, April 26, 2024
The S&P 500, and its ETF analogue SPY, is roughly breakeven for the year, which is crazy if you think about it. We had a full market crash in March due to the coronavirus pandemic. For the most part, the concerns that arose in March haven’t come close to being resolved; yet the stock market […]
For nearly two years, gold’s been on quite a run. In fact, the precious metal is getting close to an all-time high. That hasn’t happened in nearly a decade. Investing in gold is a tricky business. Historically it seems that gold likes to run one of two ways: it’s either very hot or very cold, […]
Pfizer (PFE) just announced the U.S. government will pay $1.95 billion for PFE to produce and deliver 100 million doses of its COVID vaccine once the U.S. declares it’s safe and effective. Under the agreement, the U.S. can acquire an additional 500 million doses from PFE. “Through Operation Warp Speed, we are assembling a portfolio of vaccines […]
The 2020 second-quarter earnings season promises to be full of surprises – both positive and negative. Shareholders of stocks in index funds like SPY, DIA, and QQQ may be in for a rougher ride than they’d normally expect. With a large portion of the U.S. economy, including companies in SPY, DIA, and QQQ, shut down […]
Owens & Minor (OMI) had been flying under Wall Street’s radar until it preannounced earnings this week. The medical supplies provider told the market it is essentially doubling its previous adjusted net income guidance. OMI raised projections for net income from $0.50 to $0.60 for the year to between $1.00 and $1.20. OMI said it […]
Electric vehicles have been all the rage lately in the stock and options market. NIO (NIO) has been no exception to this. The company is sometimes called the “Tesla of China” and actually has $1 billion worth of sales already. However, the huge run up in the stock price gave NIO an extremely high valuation, […]
Let’s dream for a moment. It’s November 2021. A coronavirus vaccine for was found in late December 2020. Due to pre-ramping of production facilities, 100% of the U.S. population has been vaccinated. COVID-19 is no more. Given this possible reality, where are you going to do your holiday shopping? Are you geared up for Black […]
Since bottoming out in March 2020, Fate Therapeutics (FATE) has run from a low of $19.91 to a current price of $35.50 with plenty of catalysts. For one, FATE just entered into an exclusive license agreement with Baylor College of Medicine covering alloimmune defense receptors, a first-in-class approach that renders off-the-shelf allogeneic cell products resistant […]
The financial news focuses on the major stock market indexes. These are the Dow Jones Industrial Average (DJIA), the S&P 500, and the NASDAQ Composite Index (NASDAQ). However, the effects of the coronavirus pandemic on different sectors of the economy has these indexes painting an incomplete picture of what’s happening in the U.S. stock market. […]
In a year of unpredictable market action, perhaps the most eye-opening moves are occurring in electric vehicle (EV) stocks. EV companies like TSLA are all the rage right now. Just about any stock that has some relationship to electric vehicles sees a ton of action (in the stock and the options). Just look at what […]
